BioPharmX Corporation To Present At 27th Annual Ro
Post# of 223

MENLO PARK, Calif., March 3, 2015 /PRNewswire/ -- BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that Jim Pekarsky, chief executive officer and co-founder of BioPharmX, will present at the 27th Annual Roth Capital Partners Conference on Wednesday, March 11 at 9:00 a.m. PDT at the Ritz-Carlton, Laguna Niguel in Dana Point, California.
Mr. Pekarsky will provide an overview of BioPharmX's business strategy as it pursues bringing novel products to market, including the company's recent commercial launch of VioletTM iodine, a new, once-daily pill for relief of premenstrual breast discomfort. At launch, Violet iodine was immediately available at Walgreen Co.'s drugstore.com™ web store and BioPharmX anticipates executing additional distribution agreements for Violet iodine with other large retail chains.
A live and archived webcast of the presentation will be available on the Investors page of the BioPharmX website at http://biopharmx.investorroom.com/.

